» Articles » PMID: 34023945

Allicin Ameliorates Aluminium- and Copper-induced Cognitive Dysfunction in Wistar Rats: Relevance to Neuro-inflammation, Neurotransmitters and Aβ Analysis

Overview
Publisher Springer
Specialty Biochemistry
Date 2021 May 23
PMID 34023945
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a multifactorial neurological disorder associated with neuropathological and neurobehavioral changes, like cognition and memory loss. Pathological hallmarks of AD comprise oxidative stress, formation of insoluble β-amyloid (Aβ) plaques, intracellular neurofibrillary tangles constituted by hyperphosphorylated tau protein (P-tau), neurotransmitters dysbalanced (DA, NE, 5-HT, GABA and Glutamate) and metal deposition. Chronic exposure to metals like aluminium and copper causes accumulation of Aβ plaques, promotes oxidative stress, neuro-inflammation, and degeneration of cholinergic neurons results in AD-like symptoms. In the present study, rats were administered with aluminium chloride (200 mg/kg p.o) and copper sulfate (0.5 mg/kg p.o) alone and in combination for 28 days. Allicin (10 and 20 mg/kg i.p) was administered from day 7 to day 28. Spatial and recognition memory impairment analysis was performed using Morris water maze, Probe trial, and Novel Object Recognition test. Animals were sacrificed on day 29, brain tissue was isolated, and its homogenate was used for biochemical (lipid peroxidation, nitrite, and glutathione), neuro-inflammatory (IL-1β, IL-6 and TNF- α), neurotransmitters (DA, NE, 5-HT, GABA and Glutamate), Aβ level, Al concentration estimation, and Na/K-ATPase activity. In the present study, aluminium chloride and copper sulfate administration increased oxidative stress, inflammatory cytokines release, imbalanced neurotransmitters' concentration, and promoted β-amyloid accumulation and Na/K-ATPase activity. Treatment with allicin dose-dependently attenuated these pathological events via restoration of antioxidants, neurotransmitters concentration, and inhibiting cytokine release and β-amyloid accumulation. Moreover, allicin exhibited the neuroprotective effect through antioxidant, anti-inflammatory, neurotransmitters restoration, attenuation of neuro-inflammation and β-amyloid-induced neurotoxicity.

Citing Articles

Coenzyme Q10 ameliorates chemotherapy-induced cognitive impairment in mice: a preclinical study.

Kaur S, Ahuja P, Kapil L, Sharma D, Singh C, Singh A Mol Biol Rep. 2024; 51(1):930.

PMID: 39174728 DOI: 10.1007/s11033-024-09872-0.


leaves ethanolic extract counteracts cortical neurodegeneration induced by aluminum chloride in rats.

Hindawy R, Manawy S, Nafea O, Abdelhameed A, Hendawi F Toxicol Res (Camb). 2024; 13(2):tfae028.

PMID: 38455639 PMC: 10917235. DOI: 10.1093/toxres/tfae028.


Copper and cuproptosis: new therapeutic approaches for Alzheimer's disease.

Li X, Chen X, Gao X Front Aging Neurosci. 2024; 15:1300405.

PMID: 38178962 PMC: 10766373. DOI: 10.3389/fnagi.2023.1300405.


Environmental Toxins and Alzheimer's Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation.

Dhapola R, Sharma P, Kumari S, Bhatti J, HariKrishnaReddy D Mol Neurobiol. 2023; 61(6):3657-3677.

PMID: 38006469 DOI: 10.1007/s12035-023-03805-x.


Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.

Scolari Grotto F, Glaser V Biometals. 2023; 37(1):3-22.

PMID: 37594582 DOI: 10.1007/s10534-023-00530-9.


References
1.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri C . The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013; 9(1):63-75.e2. DOI: 10.1016/j.jalz.2012.11.007. View

2.
Hardy J . A hundred years of Alzheimer's disease research. Neuron. 2006; 52(1):3-13. DOI: 10.1016/j.neuron.2006.09.016. View

3.
De Falco A, Kincheski G, Atrian-Blasco E, Hureau C, Ferreira S, Rey N . The aroylhydrazone INHHQ prevents memory impairment induced by Alzheimer's-linked amyloid-β oligomers in mice. Behav Pharmacol. 2020; 31(8):738-747. DOI: 10.1097/FBP.0000000000000578. View

4.
Chakrabarti S, Khemka V, Banerjee A, Chatterjee G, Ganguly A, Biswas A . Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment. Aging Dis. 2015; 6(4):282-99. PMC: 4509477. DOI: 10.14336/AD.2014.002. View

5.
Jangra A, Kasbe P, Pandey S, Dwivedi S, Gurjar S, Kwatra M . Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus. Biol Trace Elem Res. 2015; 168(2):462-71. DOI: 10.1007/s12011-015-0375-7. View